|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1 Pt 1
|
|
pubmed:dateCreated |
1993-2-11
|
|
pubmed:abstractText |
The purpose of our study was to evaluate the effects of three dosages of transdermally administered 17 beta-estradiol on markers of bone loss in women who had recently undergone surgical menopause.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0002-9378
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
168
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
114-21
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8420311-Adult,
pubmed-meshheading:8420311-Bone Density,
pubmed-meshheading:8420311-Calcium,
pubmed-meshheading:8420311-Cholesterol,
pubmed-meshheading:8420311-Dose-Response Relationship, Drug,
pubmed-meshheading:8420311-Double-Blind Method,
pubmed-meshheading:8420311-Estradiol,
pubmed-meshheading:8420311-Estrogen Replacement Therapy,
pubmed-meshheading:8420311-Female,
pubmed-meshheading:8420311-Humans,
pubmed-meshheading:8420311-Hydroxyproline,
pubmed-meshheading:8420311-Hysterectomy,
pubmed-meshheading:8420311-Injections, Intradermal,
pubmed-meshheading:8420311-Middle Aged,
pubmed-meshheading:8420311-Osteoporosis, Postmenopausal
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
